Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Bio Rad Laboratories Inc (NYSE:BIO)

191.58
BATS BZX Real-Time Price
As of 3:03pm ET
 -0.42 / -0.22%
Today’s Change
129.07
Today|||52-Week Range
194.25
+5.10%
Year-to-Date
New Strong Sell Stocks for February 22nd
Feb 22 / Zacks.com - Paid Partner Content
New Strong Sell Stocks for February 17th
Feb 17 / Zacks.com - Paid Partner Content
MedTech Stocks' Earnings Due on Feb 23: TFX, SAUHF, BIO, PDCO
Feb 22 / Zacks.com - Paid Partner Content
 

Today’s Trading

Previous close192.00
Today’s open189.10
Day’s range187.31 - 192.62
Volume15,314
Average volume (3 months)171,671
Market cap$4.7B
Dividend yield--
Data as of 3:03pm ET, 02/24/2017

Growth & Valuation

Earnings growth (last year)+26.23%
Earnings growth (this year)-21.20%
Earnings growth (next 5 years)-4.24%
Revenue growth (last year)-7.15%
P/E ratio57.5
Price/Sales2.02
Price/Book2.26

Competitors

 Today’s
change
Today’s
% change
BRKRBruker Corp+0.61+2.53%
PKIPerkinElmer Inc-0.28-0.51%
QGENQiagen NV-0.27-0.95%
AXDXAccelerate Diagnosti...+2.50+10.10%
Data as of 3:03pm ET, 02/24/2017

Financials

Last reporting dateFebruary 24, 2017
EPS forecast (this quarter)$1.03
Annual revenue (last year)$2.0B
Annual profit (last year)$113.1M
Net profit margin5.60%

Profile

Sector
Health Technology
Industry
Medical Specialties
Chairman, President &
Chief Executive Officer
Norman D. Schwartz
Chief Operating Officer &
Executive Vice President
John Goetz
Corporate headquarters
Hercules, California

Forecasts


Search for Jobs